A Phase 1 Dose-Escalation Study of Irinotecan in Combination with 17-Allylamino-17-Demethoxygeldanamycin in Patients with Solid Tumors

出版年份 2008 全文链接

标题

作者

关键词

出版物

Volume 14, Issue 20, Pages 6704-6711

出版商

American Association for Cancer Research (AACR)

发表日期

2008-10-17

DOI

10.1158/1078-0432.ccr-08-1006

Discuss science. Find collaborators. Network.

Join a conversation

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started